| Biscoumarin-1, 2, 3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies MS Asgari, M Mohammadi-Khanaposhtani, M Kiani, PR Ranjbar, E Zabihi, ... Bioorganic chemistry 92, 103206, 2019 | 75 | 2019 |
| Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives K Pedrood, M Sherafati, M Mohammadi-Khanaposhtani, MS Asgari, ... International Journal of Biological Macromolecules 170, 1-12, 2021 | 51 | 2021 |
| The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity N Sepehri, A Iraji, A Yavari, MS Asgari, S Zamani, S Hosseini, ... Bioorganic & Medicinal Chemistry 36, 116044, 2021 | 43 | 2021 |
| Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1, 2, 3-triazole hybrids as potent α-glucosidase inhibitors M Saeedi, M Mohammadi-Khanaposhtani, MS Asgari, N Eghbalnejad, ... Bioorganic & medicinal chemistry 27 (23), 115148, 2019 | 39 | 2019 |
| New 1, 2, 3‐triazole–(thio) barbituric acid hybrids as urease inhibitors: design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation MS Asgari, H Azizian, M Nazari Montazer, M Mohammadi‐Khanaposhtani, ... Archiv der Pharmazie 353 (9), 2000023, 2020 | 31 | 2020 |
| Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies MS Asgari, M Mohammadi-Khanaposhtani, Z Sharafi, MA Faramarzi, ... Molecular Diversity 25, 877-888, 2021 | 28 | 2021 |
| Arylmethylene hydrazine derivatives containing 1, 3-dimethylbarbituric moiety as novel urease inhibitors K Pedrood, H Azizian, MN Montazer, M Mohammadi‐Khanaposhtani, ... Scientific reports 11 (1), 10607, 2021 | 22 | 2021 |
| Design, synthesis and biological evaluation of novel phthalimide-Schiff base-coumarin hybrids as potent α-glucosidase inhibitors M Sherafati, M Mohammadi-Khanaposhtani, S Moradi, MS Asgari, ... Chemical Papers 74, 4379-4388, 2020 | 22 | 2020 |
| Novel (thio)barbituric-phenoxy-N-phenylacetamide derivatives as potent urease inhibitors: synthesis, in vitro urease inhibition, and in silico evaluations S Sedaghati, H Azizian, MN Montazer, M Mohammadi-Khanaposhtani, ... Structural Chemistry 32, 37-48, 2021 | 20 | 2021 |
| New quinoxalin‐1, 3, 4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies R Mirzazadeh, MS Asgari, E Barzegari, K Pedrood, ... Archiv der Pharmazie 354 (9), 2000471, 2021 | 16 | 2021 |
| Quinazolinone-dihydropyrano [3, 2-b] pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic M Sherafati, R Mirzazadeh, E Barzegari, M Mohammadi-Khanaposhtani, ... Bioorganic chemistry 109, 104703, 2021 | 16 | 2021 |
| Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors A Nasli Esfahani, A Iraji, A Alamir, S Moradi, MS Asgari, S Hosseini, ... Molecular Diversity, 1-15, 2021 | 15 | 2021 |
| Magnetic silica nanoparticle-supported copper complex as an efficient catalyst for the synthesis of novel triazolopyrazinylacetamides with improved antibacterial activity MS Asgari, S Sepehri, S Bahadorikhalili, PR Ranjbar, R Rahimi, ... Chemistry of Heterocyclic Compounds 56, 488-494, 2020 | 15 | 2020 |
| Novel and efficient synthesis of triazolobenzodiazepine analogues through the sequential Ugi 4CR-click-N-arylation reactions MS Asgari, M Soheilizad, PR Ranjbar, B Larijani, R Rahimi, M Mahdavi Tetrahedron Letters 60 (8), 583-585, 2019 | 14 | 2019 |
| Application of porphyrin modified sba-15 in adsorption of lead ions from aqueous media MS Asgari, A Zonouzi, R Rahimi, M Rabbani Orient. J. Chem 31 (3), 1537-1544, 2015 | 14 | 2015 |
| Design, synthesis, biological evaluation, and molecular docking study of thioxo-2, 3-dihydroquinazolinone derivative as tyrosinase inhibitors N Sepehri, M Khoshneviszadeh, SM Farid, SS Moayedi, MS Asgari, ... Journal of Molecular Structure 1253, 132283, 2022 | 11 | 2022 |
| Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin‐4(3H)‐One Containing Different Aryl Acetohydrazides as Tyrosinase Inhibitors M Hajimiri, M Khosravikia, M Khoshneviszadeh, K Pedrood, SZ Hosseini, ... Chemistry & Biodiversity 19 (7), e202100964, 2022 | 9 | 2022 |
| Design, synthesis, in vitro and in silico biological assays of new quinazolinone-2-thio-metronidazole derivatives S Ansari, M Mohammadi-Khanaposhtani, MS Asgari, EN Esfahani, ... Journal of Molecular Structure 1244, 130889, 2021 | 9 | 2021 |
| Copper Supported onto Magnetic Nanoparticles as an Efficient Catalyst for the Synthesis of Triazolobenzodiazepino[7,1‐b]quinazolin‐11(9H)‐ones via Click N‐Arylation Reactions MS Asgari, S Bahadorikhalili, R Rahimi, M Mahdavi chemistryselect 6 (6), 1385-1392, 2021 | 9 | 2021 |
| Design, synthesis, biological evaluation, and docking study of new acridine‐9‐carboxamide linked to 1, 2, 3‐triazole derivatives as antidiabetic agents targeting α‐glucosidase MS Asgari, B Tahmasebi, S Mojtabavi, MA Faramarzi, R Rahimi, ... Journal of Heterocyclic Chemistry 57 (12), 4348-4357, 2020 | 8 | 2020 |
Mohammad MahdaviAssistant Professor of Endocrinology & Metabolism Research Institute,Tehran University of MedicalVerified email at tums.ac.ir
